Assessment of patient satisfaction with ebastine fast-dissolving tablets in patients suffering from allergic rhinitis

Objective: The aim of this study was to assess patient satisfaction with ebastine fast-dissolving tablets (FDT) using the Treatment Satisfaction Questionnaire for Medication (TSQM). Research, design and methods: This was an international, multicenter, observational study involving patients with at least 1-year history of intermittent allergic rhinitis or persistent allergic rhinitis and who had received a prescription for ebastine FDT (20 mg) in the last 2 months. Investigators collected demographic data, medical history, a completed TSQM questionnaire, and responses regarding perception of onset of action, intensity of rhinitis symptoms, tolerability and their preference compared with previous therapy. Results: Validated TSQM questionnaires were collected from 461 patients and the overall ratings for effectiveness, side effects, convenience and global satisfaction were all very high for ebastine FDT. A total of 79% of patients reported a fast or very fast onset of action. On the last day of treatment pat...